| dc.contributor.author |
Tegenu Chanie |
|
| dc.date.accessioned |
2025-04-09T09:10:01Z |
|
| dc.date.available |
2025-04-09T09:10:01Z |
|
| dc.date.issued |
2022-11 |
|
| dc.identifier.uri |
http://ir.uog.edu.et/xmlui/handle/123456789/6808 |
|
| dc.description.abstract |
Chemotherapy induced neutropenia, febrile neutropenia, thrombocytopenia and anemia were the common toxicities among breast cancer patients treated with doxorubicincyclophosphamide followed by paclitaxel regimen. Those toxicities may lead to chemotherapy dose adjustment, delay and discontinuation that may compromise therapeutic outcomes. |
|
| dc.language.iso |
en_US |
en_US |
| dc.publisher |
University of Gondar |
|
| dc.subject |
Breast cancer |
en_US |
| dc.title |
Management practice of hematologic toxicities and its determinants among breast cancer patients treated with doxorubicin-cyclophosphamide followed by paclitaxel regimen in cancer centers, Northwest Ethiopia, 2022 |
en_US |
| dc.type |
Thesis |
en_US |